Segment disclosures

Company overview

Ortho Clinical Diagnostics Holdings plc

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

7 dimension combinations 55 retained observations 9 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Greater China · Reportable Segment

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=ocdx:GreaterChinaMember;us-gaap:StatementBusinessSegmentsAxis=ocdx:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2021-04-05 – 2021-07-0458500000 USD20210809Open filing evidence
2021-01-04 – 2021-07-04113500000 USD20210809Open filing evidence
2020-03-30 – 2020-06-2843300000 USD20210809Open filing evidence
2019-12-30 – 2020-06-2889600000 USD20210809Open filing evidence

Other · Reportable Segment

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=ocdx:OtherMember;us-gaap:StatementBusinessSegmentsAxis=ocdx:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2021-01-04 – 2022-01-02263200000 USD20220308Open filing evidence
2019-12-30 – 2021-01-03228700000 USD20220308Open filing evidence
2018-12-31 – 2019-12-29265000000 USD20220308Open filing evidence

Americas · Reportable Segment

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=srt:AmericasMember;us-gaap:StatementBusinessSegmentsAxis=ocdx:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2022-01-03 – 2022-04-03315400000 USD20220510Open filing evidence
2021-01-04 – 2022-01-021228900000 USD20220308Open filing evidence
2021-07-05 – 2021-10-03306500000 USD20211108Open filing evidence
2021-01-04 – 2021-10-03924200000 USD20211108Open filing evidence
2021-04-05 – 2021-07-04296300000 USD20210809Open filing evidence
2021-01-04 – 2021-07-04617700000 USD20210809Open filing evidence
2021-01-04 – 2021-04-04321400000 USD20220510Open filing evidence
2019-12-30 – 2021-01-031067300000 USD20220308Open filing evidence
2020-06-29 – 2020-09-27264200000 USD20211108Open filing evidence
2019-12-30 – 2020-09-27755800000 USD20211108Open filing evidence
2020-03-30 – 2020-06-28241100000 USD20210809Open filing evidence
2019-12-30 – 2020-06-28491700000 USD20210809Open filing evidence
2018-12-31 – 2019-12-291042500000 USD20220308Open filing evidence

EMEA · Reportable Segment

Statement Geographical · Statement Business Segments

Source dimensions srt:StatementGeographicalAxis=us-gaap:EMEAMember;us-gaap:StatementBusinessSegmentsAxis=ocdx:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2021-04-05 – 2021-07-0467800000 USD20210809Open filing evidence
2021-01-04 – 2021-07-04136300000 USD20210809Open filing evidence
2020-03-30 – 2020-06-2851000000 USD20210809Open filing evidence
2019-12-30 – 2020-06-28109600000 USD20210809Open filing evidence

Reportable Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ocdx:ReportableSegmentMember
PeriodValueUnitFiledEvidence
2022-01-03 – 2022-04-03438700000 USD20220510Open filing evidence
2021-01-04 – 2022-01-022042800000 USD20220308Open filing evidence
2021-07-05 – 2021-10-03459300000 USD20211108Open filing evidence
2021-01-04 – 2021-10-031326800000 USD20211108Open filing evidence
2021-04-05 – 2021-07-04422600000 USD20210809Open filing evidence
2021-01-04 – 2021-07-04867500000 USD20210809Open filing evidence
2021-01-04 – 2021-04-04444900000 USD20220510Open filing evidence
2019-12-30 – 2021-01-031766200000 USD20220308Open filing evidence
2020-06-29 – 2020-09-27395500000 USD20211108Open filing evidence
2019-12-30 – 2020-09-271086300000 USD20211108Open filing evidence
2020-03-30 – 2020-06-28335400000 USD20210809Open filing evidence
2019-12-30 – 2020-06-28690900000 USD20210809Open filing evidence
2018-12-31 – 2019-12-291801500000 USD20220308Open filing evidence

Reportable Segment · Greater China

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ocdx:ReportableSegmentMember;srt:StatementGeographicalAxis=ocdx:GreaterChinaMember
PeriodValueUnitFiledEvidence
2022-01-03 – 2022-04-0354500000 USD20220510Open filing evidence
2021-01-04 – 2022-01-02274400000 USD20220308Open filing evidence
2021-07-05 – 2021-10-0385600000 USD20211108Open filing evidence
2021-01-04 – 2021-10-03199100000 USD20211108Open filing evidence
2021-01-04 – 2021-04-0455000000 USD20220510Open filing evidence
2019-12-30 – 2021-01-03229600000 USD20220308Open filing evidence
2020-06-29 – 2020-09-2772700000 USD20211108Open filing evidence
2019-12-30 – 2020-09-27162300000 USD20211108Open filing evidence
2018-12-31 – 2019-12-29242500000 USD20220308Open filing evidence

Reportable Segment · EMEA

Statement Business Segments · Statement Geographical

Source dimensions us-gaap:StatementBusinessSegmentsAxis=ocdx:ReportableSegmentMember;srt:StatementGeographicalAxis=us-gaap:EMEAMember
PeriodValueUnitFiledEvidence
2022-01-03 – 2022-04-0368700000 USD20220510Open filing evidence
2021-01-04 – 2022-01-02276300000 USD20220308Open filing evidence
2021-07-05 – 2021-10-0367200000 USD20211108Open filing evidence
2021-01-04 – 2021-10-03203500000 USD20211108Open filing evidence
2021-01-04 – 2021-04-0468500000 USD20220510Open filing evidence
2019-12-30 – 2021-01-03240600000 USD20220308Open filing evidence
2020-06-29 – 2020-09-2758600000 USD20211108Open filing evidence
2019-12-30 – 2020-09-27168200000 USD20211108Open filing evidence
2018-12-31 – 2019-12-29251500000 USD20220308Open filing evidence